Replies to post #7530 on Sorrento Therapeutics Inc (SRNE)

[RMacchio]

I believe the biggest lapse in credibility came with the statements back in the summer regarding COVI-TRACK and COVI-TRACE. For example, Henry Ji announced COVI-TRACE on July 29 and said "they plan to submit the test for FDA approval within the next few weeks." Here we are almost 5 months later with zero news about COVI-TRACE and FDA approval.

Investors will quit believing press releases when companies fail to deliver on their timelines. The only PR's we see are in reference to new acquisitions - what good are the new acquisitions if you can't deliver products to the market in a timely fashion. Even worse, investors will begin to worry that this company is spread "a mile wide and an inch deep", working on so many different thinks without being able to execute on just one of them.